SAN DIEGO, Jan. 4, 2018 /PRNewswire/ — Genelux Corporation, a privately-held biopharmaceutical company focused on the development of its proprietary oncolytic immunotherapy platform, is pleased to announce that Gynecologic Oncology Associates/Women’s Cancer Research Foundation (GOA/WCRF)…
